During the last session, Adicet Bio Inc (NASDAQ:ACET)’s traded shares were 0.59 million, with the beta value of the company hitting 1.99. At the end of the trading day, the stock’s price was $0.99, reflecting an intraday gain of 10.27% or $0.09. The 52-week high for the ACET share is $3.04, that puts it down -207.07 from that peak though still a striking 18.18% gain since the share price plummeted to a 52-week low of $0.81. The company’s market capitalization is $81.73M, and the average intraday trading volume over the past 10 days was 2.84 million shares, and the average trade volume was 963.33K shares over the past three months.
Adicet Bio Inc (ACET) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.50. ACET has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it.
Adicet Bio Inc (NASDAQ:ACET) trade information
Adicet Bio Inc (ACET) registered a 10.27% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 10.27% in intraday trading to $0.99, hitting a weekly high. The stock’s 5-day price performance is 2.77%, and it has moved by 6.67% in 30 days. Based on these gigs, the overall price performance for the year is -64.19%. The short interest in Adicet Bio Inc (NASDAQ:ACET) is 2.97 million shares and it means that shorts have 8.37 day(s) to cover.
The consensus price target of analysts on Wall Street is $32.5, which implies an increase of 96.95% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $27 and $38 respectively. As a result, ACET is trading at a discount of -3738.38% off the target high and -2627.27% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 19.75%. While earnings are projected to return 51.96% in 2025, the next five years will return 22.99% per annum.
ACET Dividends
Adicet Bio Inc is due to release its next quarterly earnings in March. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Adicet Bio Inc (NASDAQ:ACET)’s Major holders
Adicet Bio Inc insiders own 2.76% of total outstanding shares while institutional holders control 69.38%, with the float percentage being 71.34%. ORBIMED ADVISORS LLC is the largest shareholder of the company, while 77.0 institutions own stock in it. As of 2024-06-30, the company held over 11.45 million shares (or 12.6303% of all shares), a total value of $13.85 million in shares.
The next largest institutional holding, with 8.22 million shares, is of TANG CAPITAL MANAGEMENT LLC’s that is approximately 9.0663% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $9.94 million.
Also, the Mutual Funds coming in first place with the largest holdings of Adicet Bio Inc (ACET) shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . Data provided on Sep 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 2.07 shares. This amounts to just over 2.51 percent of the company’s overall shares, with a $2.06 million market value. The same data shows that the other fund manager holds slightly less at 1.08, or about 1.31% of the stock, which is worth about $1.07 million.
